Cutaneous porphyria in a neonate with tyrosinaemia type 1

被引:0
|
作者
Serge Vanden Eijnden
Denise Blum
Anne Clercx
Philippe Goyens
Corine De Laet
Esther Vamos
机构
[1] Neonatal Intensive Care Unit,
[2] University Hospital for Children Queen Fabiola,undefined
[3] Université Libre de Bruxelles (U.L.B.),undefined
[4] 15 av. J.J.Crocq,undefined
[5] 1020 Brussels,undefined
[6] Belgium e-mail: svdeijnd@ulb.ac.be Tel.: +32-2-4773250,undefined
[7] Fax: +32-2-4773295 ,undefined
[8] Department of Paediatrics,undefined
[9] University Hospital for Children Queen Fabiola,undefined
[10] Brussels,undefined
[11] Belgium,undefined
[12] Department of Medical Genetics,undefined
[13] University Hospital for Children Queen Fabiola,undefined
[14] Brussels,undefined
[15] Belgium,undefined
来源
关键词
Key words Photosensitivity; Porphyria; Tyrosinaemia type 1; NTBC; Bronze baby syndrome;
D O I
暂无
中图分类号
学科分类号
摘要
A term infant born to consanguineous parents presented at birth with hypoglycaemia, thrombocytopenia, coagulopathy and hyperbilirubinaemia associated with polycythaemia due to delayed cord clamping. Despite phototherapy and correction of polycythaemia by partial exchange transfusion, coagulopathy, hypoglycaemia and conjugated hyperbilirubinaemia persisted, suggesting hepatic failure. Metabolic work-up led to the diagnosis of tyrosinaemia type 1 on day 4. Two – (2-nitro-4-trifluoromethylbenzoyl) – 1,3 cyclohexanedione (NTBC) treatment, started on day 5, resulted in progressive clinical improvement and unambiguous biochemical response. Severe skin purpuric lesions occurred in areas exposed to phototherapy. These resolved slowly after its discontinuation. Urine analysis sampled just before and 6 days after starting NTBC treatment showed high levels of type 1 coproporphyrin isomers. Such findings do not seem directly related to tyrosinaemia type 1 where succinylacetone inhibits δ-aminolevulinic acid (δ-ALA) dehydratase and where the accumulation of δ-ALA results in neurotoxicity without photosensitivity.
引用
收藏
页码:503 / 506
页数:3
相关论文
共 50 条
  • [31] CUTANEOUS MANIFESTATIONS OF PORPHYRIA
    DISCOMBE, G
    TREIP, CS
    BMJ-BRITISH MEDICAL JOURNAL, 1953, 2 (4846): : 1134 - 1136
  • [32] PORPHYRIA WITH CUTANEOUS MANIFESTATIONS
    BRUNSTING, LA
    MASON, HL
    ARCHIVES OF DERMATOLOGY AND SYPHILOLOGY, 1949, 60 (01): : 66 - 81
  • [33] Hyperinsulinism in tyrosinaemia type I
    Baumann, U
    Preece, MA
    Green, A
    Kelly, DA
    McKiernan, PJ
    JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 (02) : 131 - 135
  • [34] TREATMENT OF CUTANEOUS PORPHYRIA
    HUNTER, GA
    DONALD, GF
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 1977, 18 (01) : 1 - 3
  • [35] CUTANEOUS PORPHYRIA IN THE ADULT
    BOLGERT, M
    CANIVET, J
    BRITISH JOURNAL OF DERMATOLOGY, 1954, 66 (8-9) : 312 - 317
  • [36] CUTANEOUS PORPHYRIA IN EGYPTIANS
    ELMOFTY, AM
    BRITISH JOURNAL OF DERMATOLOGY, 1964, 76 (06) : 268 - 277
  • [37] Differentiation of cutaneous Porphyria
    Adamczyk, A. K.
    Ulmer, A.
    Fierlbeck, G.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 : 179 - 179
  • [38] CUTANEOUS SYMPTOMS OF PORPHYRIA
    BERGOEN, H
    LILLE MEDICAL, 1972, 17 (06): : 914 - &
  • [39] Experience of nitisinone for the pharmacological treatment of hereditary tyrosinaemia type 1
    Santra, Saikat
    Baumann, Ulrich
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (07) : 1229 - 1236
  • [40] Liver Transplantation for Hereditary Tyrosinaemia Type 1 in the United Kingdom
    McKiernan, Patrick
    HEREDITARY TYROSINEMIA: PATHOGENESIS, SCREENING AND MANAGEMENT, 2017, 959 : 85 - 91